LifeTech Scientific, Yeahka share sales net HK$1.9bn

By Jonathan Breen
04 Dec 2020

Medical device maker LifeTech Scientific Corp tapped the Hong Kong market for HK$930m ($120m) in fresh equity on Thursday.

The Chinese company offered investors 287.3m primary shares, equal to 6.21% of its enlarged share capital. It appointed Citi to run an accelerated bookbuild after local markets closed.

LifeTech ultimately priced the stock at HK$3.23, treating investors to a 11.6% discount to its last close at HK$3.66. The ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial